2239527
Andrenergic Agonist Drugs
- Epinephrine
- Direct acting adrenergic agonist
that stimulates all a- and B-
adrenergic receptors
- a1
Effector
Organs
- Blood Vessels
- Constriction
- Constriction
- Pancreas
- Inhibition of insulin secretion
- Inhibition of insulin secretion
- Intestine and bladder
- Relaxation and Constriction of the
sphincters
- Relaxation and Constriction of the
sphincters
- Blood Vessels
- a1
Effector
Organs
- a2
Effector
Organs
- Postganglionic
- Inhibition of norepinephrine release
- Inhibition of norepinephrine release
- CNS
- Increase in potassium
conductance
- Increase in potassium
conductance
- Platelets
- Aggregation
- Aggregation
- Postganglionic
- B1
Effector
Organs
- Heart
- Increased heart rate,
increased contractility,
increased conduction
velocity
- Increased heart rate,
increased contractility,
increased conduction
velocity
- Fat Cell
- Lipolysis
- Lipolysis
- Heart
- B2
Effector
Organs
- Blood vessels
- Dilation
- Dilation
- Bronchioles
- Dilation
- Dilation
- Uterus
- Relaxation
- Relaxation
- Kidneys
- Renin Secretion
- Renin Secretion
- Liver
- Gluycogenesis, gluconeogenesis,
- Gluycogenesis, gluconeogenesis,
- Pancreas
- Insulin secretion
- Insulin secretion
- Blood vessels
- Cardiac stimulant that increases
contractibility and heart rate,
bronchospasm in asthma, COPD
- Intravenous, intramuscular, subcutaneous,
intraosseous, oral inhalation, endotracheal,
and topical
- Adverse effects include anxiety,
headache, tremors, pallor, sweating,
nausea, vomiting,hypertension,
tachycardia, cardiac arrhythmias,
cardiac ischemia, and intracranial
hemorrhage
- Intravenous, intramuscular, subcutaneous,
intraosseous, oral inhalation, endotracheal,
and topical
- Direct acting adrenergic agonist
that stimulates all a- and B-
adrenergic receptors
- Norepinephrine
- Vasopressor: The ability of a substance to
cause vasoconstriction of blood vessels and
resultant increases in blood pressure
- a1, a2, B1
receptors
- Intravenously
- Most commonly used to
restore blood pressure
- Adverse effects include: enhanced
plasma volume depletion, and
enhanced damage to the bowels,
kidney, and liver
- Vasopressor: The ability of a substance to
cause vasoconstriction of blood vessels and
resultant increases in blood pressure
- Ephedrine
- Adverse effects include: excessive CNS stimulation,
anxiety, restlessness, headache, blurred vision,
insomnia, seizures, palpatations, arrhythmias, pallor,
tachycardia, chest pain, and severe hypertension
- Precautions: Prolonged use may produce a
syndrome resembling an anxiety state.
Tolerance to ephedrine sulfate may develop,
but temporary discontinuance to the drug
restores its original effectiveness.
- a1, a2, B1 and B2
- Adverse effects include: excessive CNS stimulation,
anxiety, restlessness, headache, blurred vision,
insomnia, seizures, palpatations, arrhythmias, pallor,
tachycardia, chest pain, and severe hypertension
- Dopamine
- Indications: Treatment of
shock states, low cardiac
output syndromes, and
hypotension, and as an
adjunct to increase cardiac
output and blood pressure
during cardiopulmonary
resuscitation
- High Dose: The
agent will promote
vasoconstriction by
directly stimulating
a- adrenergic
recptors and by
causing the release
of norepinephrine
from sympathetic
nerve terminals
- Low Dose:At low and
moderate doses, dopamine
cause dopaminergic and
B1- adrenergic effects,
resulting in increased
renal and splanchnic blood
flow and increased cardiac
contractibility,
respectively.
- Adverse Effects:
Hypotension, hypertension,
ectopic beats, tachycardia,
palpitations,
vasoconstriction, angina,
dyspnea, and cardiac
conduction abnormalities
and widened ORS intervals
- Indications: Treatment of
shock states, low cardiac
output syndromes, and
hypotension, and as an
adjunct to increase cardiac
output and blood pressure
during cardiopulmonary
resuscitation
Möchten Sie kostenlos Ihre eigenen Mindmaps mit GoConqr erstellen? Mehr erfahren.